Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022

DGAP-News: Dermapharm Holding SE


/ Key word: Forecast





Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022






29.03.2022 / 07:30



The issuer... | March 29, 2022

Related Keywords

Brehna ,Sachsen Anhalt ,Germany ,Austria ,United States ,Munich ,Bayern ,Spain ,Ukraine ,Spanish ,German ,Britta Hamberger ,Hans Georg Feldmeier ,Branded Pharmaceuticals ,Dermapharm Holding Se ,Dermapharm Holding ,Investor Relations Corporate Communications ,Executive Board ,Dermapharm Holding Se Stock Exchange ,News ,Information ,Press Release ,Dermapharm ,Molding ,Key ,Ontinuous ,Growth ,F ,Group ,Revenues ,End ,Djusted ,Bitda ,N ,022 Dmp De000a2gs5d8 ,